Dr. Alsabbagh’s research interests are in pharmacoepidemiology of chronic medications, in particular cardiovascular medications. His research includes employing administrative databases to examine the utilization and health-outcomes of chronic medications. Dr. Alsabbagh is also pursuing research investigating the comparative effectiveness and safety of chronic medications. The effect of health policy on appropriate use of chronic medications is also a major component of Dr. Alsabbagh’s research. Also, he evaluates the effects of pharmacists’ new services within expanding scope of practice on patients’ outcome and health system expenditures.
Office: PHR 3006
Phone: 519-888-4567, ext.21382
- Pharmacoepidemiology of chronic medications
- Health-outcomes of chronic medications
- The effects of pharmacists’ expanding scope of practice
- Pharmacoepidemiology of cardiovascular diseases (CVD) and diabetes medications
- The assessment of drug effectiveness and safety using real life data
- Pharmacoeconomics including the effects of health policy on drug utilization and costs
Dr. Alsabbagh teaches and coordinates courses at the undergraduate and graduate levels. Course offerings have included:
PHARM 223 Integrated Patient Focused Care 4
PHARM 227 Health Systems in Society
PHARM 601/616 Thesis Proposal
Alsabbagh MW, Eurich D, Lix LM, Wilson TW, Blackburn DF. Does the association between adherence to statin medications and mortality depend on measurement approach? A retrospective cohort study. BMC Medical Research Methodology 2017. [Accepted] DOI: 10.1186/s12874-017-0339-z
Kosar L, Alsabbagh MW, Lu X, Lix L, Shevchuk Y, Teare G, Champagne A, Blackburn DF. Self-monitoring Blood Glucose Test Strip Utilization in Saskatchewan. Can J Diabetes 2017. [Accepted]
Grindrod K, Alsabbagh MW. Managing medications during Ramadan fasting. CPJ 2017 [Accepted] DOI: 10.1177/1715163517700840
Barbara Farrell, Lisa Richardson, Lalitha Raman-Wilms, David de Launay, Mhd Wasem Alsabbagh, James Conklin. Self-efficacy for deprescribing: a survey for health care professionals using evidence-based deprescribing guidelines. Res Social Adm Pharm. 2017 Jan 28. pii: S1551-7411(17)30055-4. doi: 10.1016/j.sapharm.2017.01.003
Ziegler B, Alsabbagh MW, Houle S, Wenger L, Church D, Waite N. Protecting our patients by protecting ourselves: An analysis of the personal influenza immunization rate of Ontario community pharmacists. Can Pharm J. 2016 Jul;149(4):246-55. doi: 10.1177/1715163516651630.
Alsabbagh MW, Lix LM, Eurich D, Wilson TW, Blackburn DF. Multiple versus single-domain measurements of socio-economic status (SES) for predicting non-adherence to statin medications: an observational population-based cohort study. Med Care 2016 Feb;54(2):195-204.
Renoux C, Lix LM, Patenaude V, Bresee LC, Paterson JM, Lafrance JP, Tamim H, Mahmud SM, Alsabbagh MW, Hemmelgarn B, Dormuth CR, Ernst P; and the Canadian Network of Observational Drug Effect Studies (CNODES). Investigators. Serotonin-Norepinephrine Reuptake Inhibitors and the Risk of AKI: A Cohort Study of Eight Administrative Databases and Meta-Analysis. Clin J Am Soc Nephrol. 2015 Oct 7;10(10):1716-22.
Alsabbagh MW, Mansell K, Lix LM, Teare G, Shevchuk Y, Lu X, Champagne A, Blackburn DF.Trends in prevalence, incidence and pharmacologic management of diabetes among seniors newly admitted to long-term care facilities in Saskatchewan between 2003 and 2011 CJD. 2015 Apr;39(2):138-45.
Alsabbagh MW, Lemstra M, Eurich D, Lix LM, Wilson TW, Watson E, Blackburn DF. Socioeconomic status and nonadherence to antihypertensive drugs: A systematic review and meta-analysis. Value Health. 2014;17(2):288-296.
Lemstra M, Alsabbagh MW. Proportion and risk indicators of nonadherence to antihypertensive therapy: a meta-analysis. Patient Prefer Adherence. 2014 Feb 13;8:211-8.
Alsabbagh MW, Dagenais J, Yan L, Lu X, Lix LM, Shevchuk Y, Teare GF, Blackburn DF. Use and misuse of ezetimibe: analysis of use and cost in Saskatchewan, a Canadian jurisdiction with broad access. Can J Cardiol. 2014 Feb;30(2):237-43.
Lemstra M, Alsabbagh MW, Rajakumar RJ, Rogers MR, Blackburn DF. Neighbourhood Income and Cardiac Rehabilitation Access as Determinants of Non-Attendance and Non-Completion. Can J Cardiol. 2013 Dec;29(12):1599-603.
Alsabbagh MW, Lemstra M, Eurich D, Wilson TW, Robertson P, Blackburn DF. Pharmacist intervention in cardiac rehabilitation: a randomized controlled trial. J Cardiopulm Rehabil Prev. 2012 Nov-Dec;32(6):394-9
For more on Dr. Alsabbagh's research, see his ResearchGate profile.
Professional Associations and Service
2015 Member, Board, Canadian Association for Population Therapeutics
2015 Member, Alberta Strategy for Patient-Oriented Research (SPOR) Graduate Studentship Review Committee
2000 Bachelor of Pharmacy and Pharmaceutical Chemistry (Damascus University)
2015 PhD Pharmacy (University of Saskatchewan)